Back

ABSORB bioresorbable scaffold versus Xience metallic stent in acute coronary syndromes with treated with percutaneous coronary intervention. A subanalysis of the COMPARE-ABSORB trial.

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Acute coronary syndrome - Procedural devices Clinical ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Robert-Jan Matthijs van Geuns

University Medical Centre St Radboud (UMCN), Nijmegen (Netherlands (The))

10 More presentations in this session

Presentation thumbnail
A novel risk factor of stent restenosis after drug-eluting stent implantation; Involvement of triglyceride deposit cardiomyovasculopathy, coronary atherosclerosis with triglyceride deposition
Doctor Y. Nakano (Nagakute-cho, JP)
Abstract Slides
Presentation thumbnail
Irregular protrusion area is associated with incidence of cardiac events after implantation of new generation drug-eluting stents - optical coherence tomography study.
Doctor K. YANAGAWA (Sakai, JP)
Abstract
Presentation thumbnail
Safety and effectiveness of thin-strut DES for bifurcated coronary lesions not involving left main: a RAIN (veRy thin stents for patients with left mAIn or bifurcatioN in real life) sub-analysis
Doctor F. Angelini (Turin, IT)
Abstract
Presentation thumbnail
Excimer laser coronary angioplasty can achieve favorable clinical outocomes for in-stent restenosis lesion with neoatherosclerosis
Doctor Y. Matsuhiro (Osaka, JP)
Abstract
Presentation thumbnail
Sirolimus coated balloon in small coronary vessels in diabetic and non-diabetic patients: results from NANOLUTE real world registry
Doctor S. Dani (Ahmedabad, IN)

Access the full session

Session thumbnail
Poster Session 3 - Acute coronary syndrome - Procedural devices

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources